Show simple item record

dc.contributor.authorShireman, Theresa I.
dc.contributor.authorHall, Jean P.
dc.contributor.authorRigler, Sally K.
dc.contributor.authorMoore, Janice M.
dc.date.accessioned2015-02-10T16:53:26Z
dc.date.available2015-02-10T16:53:26Z
dc.date.issued2007-06-01
dc.identifier.citationShireman, Theresa I.; Hall, Jean P.; Rigler, Sally K.; Moore, Janice M. 2007. "Medicaid's Expenditures for Newer Pharmacotherapies for Adults with Disabilities." Health Care Financing Review, 28(4):31-42.en_US
dc.identifier.issn0195-8631
dc.identifier.urihttp://hdl.handle.net/1808/16633
dc.descriptionThis is the publisher's version, also available electronically from http://www.cms.gov/Research-Statistics-Data-and-Systems/Research/HealthCareFinancingReview/List-of-Past-Articles-Items/CMS1206484.html?DLPage=1&DLFilter=2007&DLSort=2&DLSortDir=descending.en_US
dc.description.abstractMedicaid's drug expenditures have grown at double-digit inflation rates since 2000. These prescription drug costs are important contributors to increasing health care costs for disabled persons. In spite of this knowledge, little has been reported about specific patterns of medication use among disabled enrollees. We analyzed Kansas Medicaid data to describe trends in medication use patterns across 3 years among disabled beneficiaries.en_US
dc.description.sponsorshipThe authors are with the University of Kansas. The research in this article was supported by the Kansas Department of Social and Rehabilitation Services under Contract Number KAN30700/30705. Sally K. Rigler received salary support from the National Institute on Aging under Contract Number K08 AG019516. The statements expressed in this article are those of the authors and do not necessarily reflect the views or policies of the University of Kansas, Kansas Department of Social and Rehabilitation Services, the National Institute on Aging, or the Centers for Medicare & Medicaid Services (CMS).en_US
dc.publisherCenters for Medicare & Medicaid Servicesen_US
dc.relation.isversionofhttps://www.cms.gov/Research-Statistics-Data-and-Systems/Research/HealthCareFinancingReview/downloads/07Summerpg31.pdfen_US
dc.titleMedicaid's Expenditures for Newer Pharmacotherapies for Adults with Disabilitiesen_US
dc.typeArticle
kusw.kuauthorShireman, Theresa I.
kusw.kuauthorHall, Jean P.
kusw.kuauthorRigler, Sally K.
kusw.kuauthorMoore, Janice M.
kusw.kudepartmentCenter for Research on Learningen_US
kusw.kudepartmentInstitute for Health & Disability Policy Studiesen_US
kusw.kudepartmentDivision of Adult Studiesen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-7236-1807 https://orcid.org/0000-0001-6846-8783
kusw.oaversionScholarly/refereed, publisher version
kusw.oapolicyThis item does not meet KU Open Access policy criteria.
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record